Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases

被引：36
|
作者：
Qu, Yuan [1 ]
Liu, Yi [2 ]
Noor, Ahmed Fayyaz [3 ]
Tran, Johnathan [4 ]
Li, Rui [1 ]
机构：
[1] Jilin Univ, Dept Hand Surg, Hosp 2, Changchun, Jilin, Peoples R China
[2] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan, Shandong, Peoples R China
[3] Univ Massachusetts, Dept Chem, Lowell, MA USA
[4] Massachusetts Coll Pharm & Hlth Sci, Dept Premed & Hlth Studies, Boston, MA USA
来源：
NEURAL REGENERATION RESEARCH | 2019年 / 14卷 / 06期
关键词：
nerve regeneration; central nervous system; gene therapy; neurodegenerative disease; viral vector; adeno-associated virus; Alzheimer's disease; Parkinson's disease; Huntington's disease; amyotrophic lateral sclerosis; spinal muscular atrophy; neural regeneration; MUSCULAR-ATROPHY PHENOTYPE; MOUSE MODEL; ALZHEIMERS-DISEASE; CANAVAN-DISEASE; VIRAL VECTORS; DOUBLE-BLIND; AAV VECTORS; SPINAL-CORD; DELIVERY; BRAIN;
D O I：
10.4103/1673-5374.250570
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Common neurodegenerative diseases of the central nervous system are characterized by progressive damage to the function of neurons, even leading to the permanent loss of function. Gene therapy via gene replacement or gene correction provides the potential for transformative therapies to delay or possibly stop further progression of the neurodegenerative disease in affected patients. Adeno-associated virus has been the vector of choice in recent clinical trials of therapies for neurodegenerative diseases due to its safety and efficiency in mediating gene transfer to the central nervous system. This review aims to discuss and summarize the progress and clinical applications of adeno-associated virus in neurodegenerative disease in central nervous system. Results from some clinical trials and successful cases of central neurodegenerative diseases deserve further study and exploration.
引用
收藏
页码：931 / 938
页数：8
相关论文
共 50 条
  • [1] Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
    Yuan Qu
    Yi Liu
    Ahmed Fayyaz Noor
    Johnathan Tran
    Rui Li
    NeuralRegenerationResearch, 2019, 14 (06) : 931 - 938
  • [2] Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges
    Abulimiti, Amina
    Lai, Michael Siu-Lun
    Chang, Raymond Chuen-Chung
    MECHANISMS OF AGEING AND DEVELOPMENT, 2021, 199
  • [3] Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney
    Kapturczak, MH
    Chen, SF
    Agarwal, A
    ACTA BIOCHIMICA POLONICA, 2005, 52 (02) : 293 - 299
  • [4] Safety of Adeno-associated virus-based vector-mediated gene therapy—impact of vector dose
    Shubham Maurya
    Pratiksha Sarangi
    Giridhara R. Jayandharan
    Cancer Gene Therapy, 2022, 29 : 1305 - 1306
  • [5] ADENO-ASSOCIATED VIRUS VECTOR-MEDIATED LIVER GENE THERAPY FOR CRIGLER-NAJJAR SYNDROME
    Bosma, P.
    Labrune, P.
    Brunetti-Pierri, N.
    D'Antiga, L.
    Ott, M.
    Beinat, M.
    Ronchi, F.
    Mavilio, F.
    Beuers, U.
    Muro, A.
    Baumann, U.
    Mingozzi, F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S812 - S812
  • [6] Adeno-associated virus vector-mediated gene therapy for the treatment of ovarian cancer: a literature review
    Zhu, Jiaojiao
    Qin, Tiansheng
    Wei, Linzhen
    Chen, Fan
    Ding, Yaoyao
    Zhang, Qianqian
    Dang, Yamei
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [7] Adeno-associated virus vector-mediated gene therapy in a murine model of mucopolysaccharidosis type I
    Belur, Lalitha
    deMorest, Zachary
    Whitley, Chester B.
    Low, Walter C.
    McIvor, R. Scott
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S13 - S14
  • [8] Lentivirus and adeno-associated virus vector-mediated gene therapy for the treatment of sensory neurons of the PNS
    Spinoulas, A
    Fleming, J
    Ginn, SL
    Zheng, M
    Cunningham, S
    Alexander, IE
    JOURNAL OF GENE MEDICINE, 2003, 5 (05): : S12 - S12
  • [9] Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract
    F Kurosaki
    R Uchibori
    N Mato
    Y Sehara
    Y Saga
    M Urabe
    H Mizukami
    Y Sugiyama
    A Kume
    Gene Therapy, 2017, 24 : 290 - 297
  • [10] Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract
    Kurosaki, F.
    Uchibori, R.
    Mato, N.
    Sehara, Y.
    Saga, Y.
    Urabe, M.
    Mizukami, H.
    Sugiyama, Y.
    Kume, A.
    GENE THERAPY, 2017, 24 (05) : 290 - 297
12345